DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Overview Fund Activity
Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

148 hedge funds and large institutions have $1.68B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 36 closing their positions.

Holders
148
Holders Change
-5
Holders Change %
-3.27%
% of All Funds
3.27%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
33
Increased
59
Reduced
41
Closed
36
Calls
$15M
Puts
$8.16M
Net Calls
+$6.87M
Net Calls Change
-$5.63M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$82.3M
2
Franklin Resources
2
Franklin Resources
California
$133M
3
AG
3
Artal Group
Luxembourg
$32.9M
4
Citadel Advisors
4
Citadel Advisors
Florida
$17.6M
5
RG
5
Redmile Group
California
$211M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$13.8M
2
O
2
OrbiMed
New York
$47.7M
3
MB
3
MPM BioImpact
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
Capital World Investors
5
Capital World Investors
California
$11.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
PAM
76
Panagora Asset Management
Massachusetts
$1.3M +$1.3M +31,531 New
PPA
77
Parametric Portfolio Associates
Washington
$1.29M -$291K -7,064 -18%
State of Wisconsin Investment Board
78
State of Wisconsin Investment Board
Wisconsin
$1.26M +$346K +8,400 +38%
TD Asset Management
79
TD Asset Management
Ontario, Canada
$1.22M -$94.7K -2,300 -7%
TI
80
Trexquant Investment
Connecticut
$1.22M +$885K +21,503 +264%
SEI Investments
81
SEI Investments
Pennsylvania
$1.21M +$341K +8,774 +39%
Bank of America
82
Bank of America
North Carolina
$1.2M -$4.79M -116,334 -80%
RhumbLine Advisers
83
RhumbLine Advisers
Massachusetts
$1.19M +$106K +2,569 +10%
New York State Common Retirement Fund
84
New York State Common Retirement Fund
New York
$1.18M +$417K +10,142 +55%
Morgan Stanley
85
Morgan Stanley
New York
$1.13M -$444K -10,787 -28%
AQR Capital Management
86
AQR Capital Management
Connecticut
$1.04M +$255K +6,198 +33%
Alyeska Investment Group
87
Alyeska Investment Group
Illinois
$1.03M +$1.03M +25,000 New
CS
88
Credit Suisse
Switzerland
$839K -$394K -9,566 -32%
QI
89
QS Investors
New York
$812K – – –
EAM
90
Erste Asset Management
Austria
$767K +$767K +18,300 New
LCG
91
Lisanti Capital Growth
New York
$761K +$761K +18,490 New
CSS
92
Cubist Systematic Strategies
Connecticut
$751K -$2.58M -62,705 -77%
EDRIA
93
Edmonds Duncan Registered Investment Advisors
Kansas
$731K – – –
IBT
94
International Biotechnology Trust
United Kingdom
$697K – – –
AR
95
Advisory Research
Illinois
$697K +$308K +7,481 +79%
WG
96
Winton Group
United Kingdom
$641K -$126K -3,056 -16%
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$563K +$74.3K +1,804 +15%
SO
98
STRS Ohio
Ohio
$526K – – –
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$525K -$945K -22,952 -64%
AIG
100
American International Group
New York
$511K +$2.22K +54 +0.4%
2 3
4
5 6